Suppr超能文献

Loeys-Dietz 综合征中侵袭性主动脉病变的外科治疗经验。

Surgical experience with aggressive aortic pathologic process in Loeys-Dietz syndrome.

机构信息

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

出版信息

Ann Thorac Surg. 2012 Nov;94(5):1413-7. doi: 10.1016/j.athoracsur.2012.05.111. Epub 2012 Aug 24.

Abstract

BACKGROUND

Loeys-Dietz syndrome (LDS) is a recently recognized connective tissue disorder (CTD) caused by mutations in transforming growth factor-beta receptor (TGFBR)1 and TGFBR2. Surgical outcomes of aortic repair in patients with LDS are poorly known.

METHODS

We enrolled 16 patients with TGFBR mutations identified by gene analysis in this study. Between 1993 and 2011, they underwent 41 aortic surgical procedures. Ten patients (group D: dissection group) underwent aortic repair for acute or chronic aortic dissection as a first surgical intervention, and 6 patients (group N: nondissection group) underwent surgical treatment for aortic root dilatation. The mean follow-up period was 103.7 ± 92.3 months (range, 2- 276 months).

RESULTS

There were no in-hospital deaths. In group N, valve-sparing root replacement (VSRR) was performed in all patients. The residual aorta in 9 patients (90%) from group D required further repairs, 3 times on average. Moreover, in 4 patients (40%), the aorta was entirely replaced in serial procedures. In group N, aortic dissection occurred in only 1 patient (17%). The aortic event-free rates at 5 years were 40% in group D and 80% in group N, respectively (p = 0.819). One late death due to arrhythmia occurred 1 month after VSRR. The cumulative survival rates at 5 years were 100% in group D and 83% in group N, respectively (p = 0.197).

CONCLUSIONS

Surgical outcomes for patients with LDS were satisfactory. Once aortic dissection occurred, the aorta expanded rapidly, requiring further operations. Therefore, early surgical intervention may improve prognosis by preventing a fatal aortic event.

摘要

背景

Loeys-Dietz 综合征(LDS)是一种新近被认识的结缔组织疾病(CTD),由转化生长因子-β受体(TGFBR)1 和 TGFBR2 的突变引起。LDS 患者主动脉修复的手术结果知之甚少。

方法

我们通过基因分析纳入了 16 名 TGFBR 突变患者。在 1993 年至 2011 年期间,他们接受了 41 次主动脉手术。10 名患者(D 组:夹层组)作为首次手术干预接受了急性或慢性主动脉夹层的主动脉修复,6 名患者(N 组:非夹层组)接受了主动脉根部扩张的手术治疗。平均随访时间为 103.7±92.3 个月(范围 2-276 个月)。

结果

无院内死亡。在 N 组中,所有患者均行保留瓣膜的根部替换术(VSRR)。D 组 9 名患者(90%)的残余主动脉需要进一步修复,平均修复 3 次。此外,在 4 名患者(40%)中,主动脉在连续手术中被完全替换。在 N 组中,仅 1 名患者(17%)发生主动脉夹层。D 组和 N 组的主动脉无事件生存率分别为 40%和 80%(p=0.819)。1 例 VSRR 后 1 个月因心律失常死亡。D 组和 N 组的累积生存率分别为 100%和 83%(p=0.197)。

结论

LDS 患者的手术结果令人满意。一旦发生主动脉夹层,主动脉迅速扩张,需要进一步手术。因此,早期手术干预可能通过预防致命的主动脉事件来改善预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验